Teachers Advisors’s AstraZeneca AZN Stock Holding History

Teachers Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$5.53M	Sell	68,443 -320,781	-82%	-$25.3M	0.01%	1351
2018 Q4	$29.6M	Sell	389,224 -132,313	-25%	-$10.3M	0.04%	446
2018 Q3	$41.3M	Buy	521,537 +56,633	+12%	+$4.28M	0.05%	414
2018 Q2	$32.6M	Sell	464,904 -5,799	-1%	-$417K	0.04%	503
2018 Q1	$32.9M	Sell	470,703 -25,275	-5%	-$1.75M	0.04%	468
2017 Q4	$34.4M	Buy	495,978 +32,985	+7%	+$2.22M	0.04%	473
2017 Q3	$31.4M	Sell	462,993 -46,631	-9%	-$2.95M	0.04%	473
2017 Q2	$34.7M	Buy	509,624 +40,967	+9%	+$2.68M	0.05%	429
2017 Q1	$29.2M	Buy	468,657 +75,067	+19%	+$4.37M	0.04%	484
2016 Q4	$21.5M	Buy	393,590 +15,052	+4%	+$855K	0.03%	594
2016 Q3	$24.9M	Buy	378,538 +40,213	+12%	+$2.63M	0.04%	490
2016 Q2	$20.4M	Buy	338,325 +82,830	+32%	+$4.81M	0.04%	555
2016 Q1	$14.4M	Buy	255,495 +218,766	+596%	+$13.1M	0.03%	706
2015 Q4	$2.49M	Buy	36,729 +700	+2%	+$45.9K	﹤0.01%	1463
2015 Q3	$2.29M	Buy	36,029 +10,150	+39%	+$668K	﹤0.01%	1487
2015 Q2	$1.65M	Sell	25,879 -1,819	-7%	-$125K	﹤0.01%	1816
2015 Q1	$1.9M	Sell	27,698 -784,635	-97%	-$54.5M	﹤0.01%	1688
2014 Q4	$57.2M	Buy	812,333 +766,435	+1,670%	+$54.9M	0.11%	243
2014 Q3	$3.28M	Buy	45,898 +19,600	+75%	+$1.43M	0.01%	1301
2014 Q2	$1.95M	Sell	26,298 -74,932	-74%	-$5.42M	﹤0.01%	1637
2014 Q1	$6.57M	Sell	101,230 -101,562	-50%	-$6.56M	0.01%	987
2013 Q4	$12M	Buy	202,792 +6,500	+3%	+$353K	0.03%	727
2013 Q3	$10.2M	Sell	196,292 -24,183	-11%	-$1.21M	0.03%	756
2013 Q2	$10.4M	Buy	+220,475	New	+$11.2M	0.03%	705

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Teachers Advisors's AZN Position: Q1 2019 in Review

Teachers Advisors reduced its AstraZeneca (AZN) stake by 82% in Q1 2019, selling an estimated $25.3M and leaving 68,443 shares worth $5.53M. The position accounts for 0.01% of the portfolio, ranked #1351.

Teachers Advisors first reported a position in AZN in Q2 2013 and has held it in 24 quarters since. The position peaked at $57.2M in Q4 2014. 561 funds tracked by Wall St. Rank hold AZN as of Q1 2019.

Teachers Advisors held 68,443 shares of AstraZeneca worth $5.53M as of Q1 2019.
Teachers Advisors sold 320,781 AstraZeneca shares in Q1 2019, an estimated $25.3M.
AstraZeneca made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #1351 holding.
Teachers Advisors first reported a position in AstraZeneca in Q2 2013 and has held it in 24 quarters since.
Teachers Advisors's AstraZeneca position peaked at $57.2M in Q4 2014.
561 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.